Benefits Eligibility for 32 USC 502(f) Missions

A chart outlining the various Benefits Eligibility for 32 USC 502(f) Missions

Memorandum on Providing Federal Support for Governors' Use of the National Guard to Respond to COVID-19

Delegation of Authority for Reserve Component Activation Authorities during the Coronavirus Disease 2019 Response

This delegation assigns to the Service Secretaries the authority to activate Reserve Component personnel and to modify their orders as needed to employ and retain them for the COVID-19 response.

Authorization to Employ Military Medical Capabilities to Treat COVID-19 Patients

Effective immediately, the Commander, U.S Northern Command, is authorized, as he deems necessary and appropriate, to employ military medical capabilities under his operational control to treat patients who have contracted coronavirus disease 2019 (COVID-19).

Decision Memorandum on TRICARE Implementation of the "Families First Coronavirus Response Act"

The Families First Coronavirus Response Act, Public Law 116-127, Division F, Section 6006(a), limits TRICARE authority to impose copayment or other cost-sharing for novel coronavirus (COVID-19) testing and related provider visits that result in orders for or administration of Food and Drug Administration (FDA) approved, cleared, or authorized diagnostic products. In order for the Defense Health Agency (DHA) to implement, the Assistant Secretary of Defense for Health Affairs (ASD(HA)) must acknowledge the self-executing authority of the statute and direct the Director, DHA, or designee, to issue guidance implementing the statutory provisions.

DoD Guidance on the Use of Cloth Face Coverings

Effective immediately, to the extent practical, all individuals on DoD property, installations, and facilities will wear cloth face coverings when they cannot maintain six feet of social distance in public areas or work centers (this does not include in a Service member's or Service family member's personal residence on a military installation).

Policy on Accessions and Accessions Training during the COVID-19 Outbreak

The Military Departments must seek ways to maximize accessions in a responsible manner to minimize a reduction in military end strength and the potential deterioration of mid-and long-term readiness and capacity.

Transition of Military Medical Treatment Facilities from Military Departments to the Defense Health Agency during the COVID-19 Response

The Department's MTF transition plan is conditions-based. While the transition of MTFs to DHA is continuing, the COVID-19 response requirements are impacting DHA's ability to meet all required conditions. The need for the DHA and MILDEPs to refocus efforts away from the transition to support the COVID-19 response led to questions regarding the future of MTF Transition.

Pharmacy Guidance for Market MTFs

Message to Pharmacy Beneficiaries regarding military pharmacy services during the COVID-19 pandemic.

Tiered Telehealth Health Care Support for COVID-19

This memorandum establishes guidance for the use of Telehealth (TH) Information Technology (IT) tools in support of the clinical care required for patients across the spectrum of COVID-19 illness

Q & A: Policy Exception for Telehealth Use for ABA during COVID-19 Pandemic

Question and Answer: TRICARE Autism Care Demonstration (ACD): Regarding Temporary Authorization to Utilize Telehealth for CPT Code 97156 during the COVID-19 National Emergency

Policy Exception for Telehealth Use for ABA during COVID-19 Pandemic

Communication to ABA Providers Regarding Temporary Authorization to Utilize Telehealth for CPT Code 97156 During the COVID-19 National Emergency

COVID-19 Life Support Training Extension

The purpose of this memorandum is to set policy guidance within the Military Health System for American Red Cross life support training (First Aid/cardiopulmonary resuscitation (CPR)/automated external defibrillator (AED), Basic Life Support (BLS), Advanced Life Support (ALS), and Pediatric Advanced Life Support (PALS)).

Donor Self-deferral Information Sheet to Reduce the Risk of Transfusion-transmitted Zika

This info sheet is to give to potential blood donors who have traveled to Mexico, the Caribbean and Central and South America in the last 28 days. BPL 16-02, Attachment 2

Post-donation Information Sheet

This info sheet is to provide to blood donors after they give blood. BPL 16-02, Attachment 3